VALIDITY OF DATA ON NEBIVOLOL AND IVABRADINE IN A CONSENSUS DOCUMENT FOR THE MANAGEMENT OF ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
The article shows that the information on effectiveness and safety of nebivolol and ivabradine given in Russian consensus document on diagnosis and treatment of chronic heart failure in elderly and senile patients does not fully correspond to the results of randomized controlled trials SENIORS and SHIFT.